Igor Puzanov, MD, MSCI, FACP, discusses the adverse effects associated with immunotherapy and how to manage them.
Igor Puzanov, MD, MSCI, FACP
Advertisement
Articles by Igor Puzanov, MD, MSCI, FACP
The observed adverse events that have been associated with immunotherapy, especially immunotherapy combinations, have to be properly assessed against their clearly improved efficacy in patients with otherwise dismal prognosis from stage IV cancers.
Advertisement
Latest Updated Articles
Tackling the Adverse Effects of ImmunotherapyPublished: May 9th 2022 | Updated:
Taking Steps to Manage Adverse Events Associated with Checkpoint InhibitorsPublished: November 29th 2016 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Daratumumab and Hyaluronidase Plus VRd for Newly Diagnosed Multiple Myeloma
2
NP-G1-044 Receives FDA Orphan Drug Designation for Pancreatic Cancer
3
Ixazomib-Based Regimens Expand Options in Relapsed/Refractory Multiple Myeloma
4
PD-L1 Expression Is More Predictive of Response to Pembrolizumab on Metastatic Sites in High-Grade Serous Ovarian Cancer
5